2024 CEI Annual SurveyPlease complete the 2024 CEI Annual Survey.

Logo

Course

Tobacco Use Disorder Treatment among People Who Use Drugs

Details

Published Date: 08/20/2024

Expiration Date: 04/23/2027

CE Credit: CME:1CNE: 1

Description

The use of tobacco products is the leading cause of preventable disease, disability and death in the United States. Although rates of cigarette smoking are on the decline, it is estimated that it leads to about 480,000 deaths annually. It is essential that providers in NYS understand tobacco use disorder and treatment options – including pharmacologic treatments, behavioral interventions and a combination approach – in order to ensure the best possible health outcomes. 

Presenter(s)

E. Jennifer Edelman,MD, MHS

E. Jennifer Edelman, MD, MHS, AAHIVS is an Associate Professor of Medicine and Public Health at Yale University School of Medicine. Certified as an internist, HIV specialist, and in Addiction Medicine, she serves as the physician consultant in Addiction Medicine Treatment Program at the Yale New Haven Hospital Nathan Smith HIV Clinic and routinely treats substance use disorders among patients with HIV. She is Director of the Center for Interdisciplinary Research on AIDS (CIRA) Clinical and Health Services Research Core, co-Director of Education at the Yale Center for Clinical Investigation, co-Chair of the Veterans Aging Cohort Study (VACS) Opioids Core, and Associate Director of the National Institute on Drug Abuse (NIDA)-funded Research in Addiction Medicine Scholars Program. Funded by NIH, her research over the past 14+ years has focused on understanding and addressing harms of substance use among individuals with and at substantial risk for HIV. She has experience applying a range of methodologies – including observational, interventional and implementation science-based approaches – and collaborating with diverse clinically and community-based partners. She enjoys mentoring juniorfaculty and trainees.

Learning Objectives

  • Review disparities in smoking prevalence and tobacco-related health disease in New York State.
  • Assess level of tobacco dependence among an adult patient population.
  • Identify evidence-based pharmacologic treatments to provide nicotine withdrawal management and support tobacco cessation.
  • Describe evidence-based behavioral interventions for tobacco use disorder.

Continuing Education Credit Information